DANAHER Inactive Instrument
DANAHER Stock Other OTC
Equities
US2358513008
Advanced Medical Equipment & Technology
| Sales 2024 * | 23.9B 32.65B | Sales 2025 * | 26B 35.53B | Capitalization | 183B 250B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.44B 6.06B | Net income 2025 * | 5.35B 7.31B | EV / Sales 2024 * | 8.01 x |
| Net Debt 2024 * | 8.58B 11.73B | Net Debt 2025 * | 2.35B 3.21B | EV / Sales 2025 * | 7.12 x |
| P/E ratio 2024 * |
41.6
x | P/E ratio 2025 * |
34.2
x | Employees | - |
| Yield 2024 * |
0.44% | Yield 2025 * |
0.47% | Free-Float | 74.92% |
More Fundamentals
* Assessed data
More news
Latest transcript on DANAHER
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Rainer Blair
CEO | Chief Executive Officer | 60 | 09-12-31 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 82-12-31 |
Alan Spoon
BRD | Director/Board Member | 72 | 99-06-30 |
Steven Rales
FOU | Founder | 72 | 82-12-31 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
2024-05-06
- Annual General Meeting
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +7.62% | 219B | |
| +11.94% | 132B | |
| +24.60% | 106B | |
| -2.66% | 62.09B | |
| +4.81% | 50.88B | |
| +11.55% | 50.8B | |
| -1.09% | 40.64B | |
| +26.82% | 31.59B | |
| +18.66% | 24.39B |
